Positron Emission Tomography (PET) studies rely on a specialized tracer to visualize metabolic activity within the body. This tracer, FDG, is a modified sugar molecule that accumulates in areas of high metabolic function. By injecting FDG into the bloodstream and tracking its distribution through PET scanners, clinicians can detect a wide range of